Afficher la notice abrégée

dc.contributor.authorVelasco Criado, Ana Purificación 
dc.contributor.authorHijazi Vega, Maruan 
dc.date.accessioned2024-01-31T12:22:22Z
dc.date.available2024-01-31T12:22:22Z
dc.date.issued2016
dc.identifier.citationVelasco, A., & Hijazi, M. (2016). Oleic acid and cholinergic dysfunction in Down Syndrome models of the central nervous system. Journal of Neurology & Neuromedicine, 1(3). https://doi.org/10.29245/2572.942X/2016/3.1029es_ES
dc.identifier.issn2572-942X
dc.identifier.urihttp://hdl.handle.net/10366/155097
dc.description.abstract[EN]Down syndrome (DS): or trisomy 21: is the most common autosomal aneuploidy and the leading genetic cause of intellectual disability. It is widely established that mental retardation is primarily a consequence of brain functioning and developmental abnormalities in neurogenesis. Some changes in the physical structure of the dendrites are a major cause of impaired synaptic plasticity of DS. The overexpression of the dual specificyty tyrsone phosphorylationregulated kinase 1A (DYRK1A): located on chromosome 21: is involved in cellular plasticity and responsible for central nervous system disturbance in DS. Oleic acid is a neurotrophic factor that promotes neuronal differentiation and increases the levels of choline acetyltransferase (ChAT). Furthermore: it has recently been shown that it induces migration and formation of new synapses in euploid cells. However: remarkably oleic acid fails to reproduce the same effects in trisomic cells. Here we review the hypothesis that oleic acid-dependent synaptic plasticity may be dependent on the lipid environment. Thus: differences in membrane composition may be essential to understand why oleic acid promotes higher cell plasticity in euploid than in trisomic cells.es_ES
dc.language.isoenges_ES
dc.subjectDown syndromees_ES
dc.subject.meshDown Syndrome *
dc.titleOleic acid and cholinergic dysfunction in Down syndrome models of the central nervous systemes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.29245/2572.942X/2016/3.1029es_ES
dc.identifier.doi10.29245/2572.942X/2016/3.1029
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.journal.titleJournal of Neurology and Neuromedicinees_ES
dc.volume.number1es_ES
dc.issue.number23es_ES
dc.page.initial1es_ES
dc.page.final5es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decssíndrome de Down *


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée